Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Nisman

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2013
Increased proliferative background in healthy women with BRCA1/2 haploinsufficiency is associated with high risk for breast cancerBenjamin Nisman, Luna Kadouri, Tanir Allweis, et al.
Anticancer Research|June 25, 2003
Prognostic factors for survival in metastatic breast cancer during first-line paclitaxel chemotherapyBenjamin Nisman, Vivian Barak, Ayala Hubert, et al.
Cancer Biomarkers : Section a of Disease Markers|December 24, 2010
Serum thymidine kinase 1 activity in breast cancerBenjamin Nisman, Tanir Allweis, Luna Kaduri, et al.
Urology|June 25, 2010
Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomyBenjamin Nisman, Vladimir Yutkin, Hovav Nechushtan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2014
Serum thymidine kinase 1 activity in the prognosis and monitoring of chemotherapy in lung cancer patients: a brief reportBenjamin Nisman, Hovav Nechushtan, Haim Biran, et al.
Anticancer Research|April 13, 2016
Serum Thymidine Kinase 1 Activity Following Nephrectomy for Renal Cell Carcinoma and Radiofrequency Ablation of Metastases to Lung and LiverBenjamin Nisman, Liat Appelbaum, Vladimir Yutkin, et al.
Clinical Chemistry and Laboratory Medicine|October 25, 2012
Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patientsBenjamin Nisman, Tanir Allweis, Luna Kadouri, et al.
Anticancer Research|October 28, 2020
Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast CancerBenjamin Nisman, Tanir M Allweis, Einat Carmon, et al.
Anticancer Research|December 31, 2021
Thyroid Hormones and Morphological Features of Primary Breast CancerAmichay Meirovitz, Benjamin Nisman, Tanir M Allweis, et al.
Anticancer Research|January 31, 2021
Elevated Free Triiodothyronine Is Associated With Increased Proliferative Activity in Triple-negative Breast CancerBenjamin Nisman, Tanir M Allweis, Einat Carmon, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2013
Increased proliferative background in healthy women with BRCA1/2 haploinsufficiency is associated with high risk for breast cancerBenjamin Nisman, Luna Kadouri, Tanir Allweis, et al.
Anticancer Research|June 25, 2003
Prognostic factors for survival in metastatic breast cancer during first-line paclitaxel chemotherapyBenjamin Nisman, Vivian Barak, Ayala Hubert, et al.
Cancer Biomarkers : Section a of Disease Markers|December 24, 2010
Serum thymidine kinase 1 activity in breast cancerBenjamin Nisman, Tanir Allweis, Luna Kaduri, et al.
Urology|June 25, 2010
Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomyBenjamin Nisman, Vladimir Yutkin, Hovav Nechushtan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2014
Serum thymidine kinase 1 activity in the prognosis and monitoring of chemotherapy in lung cancer patients: a brief reportBenjamin Nisman, Hovav Nechushtan, Haim Biran, et al.
Anticancer Research|April 13, 2016
Serum Thymidine Kinase 1 Activity Following Nephrectomy for Renal Cell Carcinoma and Radiofrequency Ablation of Metastases to Lung and LiverBenjamin Nisman, Liat Appelbaum, Vladimir Yutkin, et al.
Clinical Chemistry and Laboratory Medicine|October 25, 2012
Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patientsBenjamin Nisman, Tanir Allweis, Luna Kadouri, et al.
Anticancer Research|October 28, 2020
Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast CancerBenjamin Nisman, Tanir M Allweis, Einat Carmon, et al.
Anticancer Research|December 31, 2021
Thyroid Hormones and Morphological Features of Primary Breast CancerAmichay Meirovitz, Benjamin Nisman, Tanir M Allweis, et al.
Anticancer Research|January 31, 2021
Elevated Free Triiodothyronine Is Associated With Increased Proliferative Activity in Triple-negative Breast CancerBenjamin Nisman, Tanir M Allweis, Einat Carmon, et al.
Pageof 3